Prof. Dr. Rolf Müller studied Pharmacy at the University of Bonn from 1986-1990, received his
approbation as a pharmacist in 1991 and finished his PhD on a pharmaceutical-microbiological topic
in 1994. From 1996-1997 he spent two years as a DFG research scholar at the University of
Washington in Seattle, USA and returned to Germany in 1998 as a junior group leader at the former
German Research Centre for Biotechnology (GBF). In 2000, he completed his habilitation thesis at the
Technical University Braunschweig about the biosynthesis of antibiotics in actinomycetes and
myxobacteria. Since October 2003, Rolf Müller holds a chair as professor of pharmaceutical
biotechnology at Saarland University and in 2009 he became managing director of the newly founded
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS). Furthermore, he heads the
department of “Microbial Natural Products” (MINS) and co-founded the PharmBioTec GmbH in
Saarbrücken.
Rolf Müller’s research is dedicated to the chemistry and biology of microbial natural products with an
emphasis on myxobacteria. Using an interdisciplinary research setting his group focusses on the
identification, modification and pharmaceutical development of new anti-infectives exhibiting
innovative mode of action.
Rolf Müller received the Phoenix-Pharmacy Research Award (2001, 2007, and 2016), the DECHEMA
Award for Natural Products Research (2002), the BioFuture Award of the Federal Ministry for
Education and Research (2003) and the DECHEMA Award of the Max-Buchner Research Foundation
(2010). He was elected member of the National Academy of Science and Engineering (acatech) in
2012 and member of the National Academy of Sciences (Leopoldina) in 2016. In May 2018, Rolf
Müller received the Inhoffen Medal which is awarded by the Helmholtz Centre for Infection Research
(HZI) and the Technical University (TU) Braunschweig.